CIBMTR Research Database
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- Center for International Blood and Marrow Transplant Research
- Study ID
- NCT01166009
- Status
- Recruiting
Conditions
- Allogeneic Stem Cell Transplantation
- Autologous Stem Cell Transplantation
- Blood Cancers
- CAR-T
- Gene Therapy
- Non-malignant Disease
- Solid Tumors
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies. A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries. Objectives: To learn more about what makes stem cell transplants and cellular therapies work well such as: * Determine how well recipients recover from their transplants or cellular therapy; * Determine how recovery after a transplant or cellular therapy can be improved; * Determine how a donor's or recipient's genetics impact recipient recovery after a transplant or cellular therapy; * Determine how access to transplant or cellular therapy for different groups of patients can be improved; * Determine how well donors recover from the collection procedures.
Key Dates
- Start date
- Jul 31, 2002
- Status verified
- Aug 2025
- Primary completion
- Jul 31, 2050
- Completion
- Jul 31, 2050
Study Design
- Enrollment
- 99,999,999 participants (estimated)
Primary Outcome Measure
A Comprehensive Source of Observational Data to assess Stem Cell Transplant [ Time Frame: Anually - on average ]
Central Contacts
- Leigh Anne Blackmon763 406 8087
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Center for International Blood and Marrow Transplant Research | Minneapolis | Minnesota | 55413 | Brandan Butler |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Brandan Butler |
Find similar trials in Minneapolis, MN
Related Studies
- Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking StudyRecruiting · Mayo Clinic · Rochester, Minnesota
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)PHASE3 · Recruiting · Merck Sharp & Dohme LLC · Tucson, Arizona
- Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic InjuriesRecruiting · Center for International Blood and Marrow Transplant Research · New Brighton, Minnesota